Trials / Sponsors / Taivex Therapeutics Corporation
Taivex Therapeutics Corporation
Industry · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Safety and Tolerability Study for T-1301 Capsules to Treat Advanced Solid Tumors Advanced Solid Tumor, Lymphoma | Phase 1 | 2021-12-19 |
| Recruiting | Safety and Tolerability Study for T-1201 Injection 100 mg Kit in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2021-06-24 |
| Active Not Recruiting | Safety and Tolerability Study for T-1101 (Tosylate) Capsules to Treat Advanced Refractory Solid Tumors Advanced Refractory Solid Tumors | Phase 1 | 2021-01-07 |
| Completed | An Extension Study for T-1101 (Tosylate) to Treat Advanced Refractory Solid Tumors Advanced Refractory Solid Tumors | Phase 1 | 2017-09-14 |
| Terminated | Safety and Tolerability Study for T-1101 (Tosylate) to Treat Advanced Refractory Solid Tumors Advanced Refractory Solid Tumors | Phase 1 | 2017-09-14 |